Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Westminster Group shares tank after article mix-up

(Sharecast News) - Managed services and security solutions company Westminster Group put out a statement on Thursday addressing a sell-off in its stock, which it linked to a mix-up regarding an article about a political entity. The company referenced an article about a cross-party political group being shut down over links to a state-owned Israeli arms company.

According to a story from Declassified UK published on Monday, an All-Party Parliamentary Group on Defence Technology pulled its website after it was revealed that it accepted cash from a defence firm linked to the Israeli government.

The title of the article read: 'Westminster group shut down over Israel funding'.

The group in question has "nothing to do with the company", AIM-listed Westminster Group said in a statement to the market.

"Furthermore, the company understands that there is also speculation about the status of the passenger security fee in Gabon - for clarification a decree has been issued putting this passenger security fee into Gabonese law stipulating it to be collected by Westminster."

Shares were down 23% at 1.7p by 1241 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.